Multicenter study for optimal categorization of extramural tumor deposits for colorectal cancer staging

Annals of Surgery

Volumn 255, Issue 4, 2012, Pages 739-746

  Ueno, Hideki ^a   Mochizuki, Hidetaka ^a   Shirouzu, Kazuo ^b   Kusumi, Takaya ^c   Yamada, Kazutaka ^d   Ikegami, Masahiro ^e   Kawachi, Hiroshi ^f   Kameoka, Shingo ^g   Ohkura, Yasuo ^h   Masaki, Tadahiko ^h   Kushima, Ryoji ⁱ   Takahashi, Keiichi ^j   Ajioka, Yoichi ^k   Hase, Kazuo ^l   Ochiai, Atsushi ^m   Wada, Ryo ⁿ   Iwaya, Keiichi ^o   Nakamura, Takahiro ^a   Sugihara, Kenichi ^f  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Department of Surgery   (Japan)

^d TAKANO HOSPITAL   (Japan)

^e JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^g TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^h KYORIN UNIVERSITY   (Japan)

ⁱ SHIGA UNIVERSITY OF MEDICAL SCIENCE HOSPITAL   (Japan)

^j TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^k NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^l Self Defense Forces Central Hospital   (Japan)

^m NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

ⁿ JUNTENDO UNIVERSITY SHIZUOKA HOSPITAL   (Japan)

^o TOKYO MEDICAL UNIVERSITY   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PRACTICE; COLORECTAL CANCER; EXTRAMURAL TUMOR DEPOSIT WITHOUT LYMPH NODE STRUCTURE; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; OBSERVER VARIATION; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84862793346     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31824b4839     Document Type: Article

References (25)

1. Desch CE, Benson AB, III, Somerfield MR, et al. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology Practice Guideline. J Clin Oncol. 2005;23:8512-8519.
2. ESMO Guidelines Working GroupVan Cutsem EJ, Oliveira J. Colon cancer: ESMO Clinical Recommendations for diagnosis, adjuvant treatment and follow-up. Ann Oncol. 2008;19:ii29-ii30.
3. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology-colon cancer (version 3. 2012). Available at: http://www.nccn.org/ professionals/physician-gls/pdf/colon.pdf. Accessed February 24, 2012.
4. Sobin LH, Wittekind CH, eds. International Union Against Cancer. TNM Classification of Malignant Tumours. 5th ed. New York, NY: Wiley-Liss; 1997.
5. Sobin LH, Wittekind CH, eds. International Union Against Cancer. TNM Classification of Malignant Tumours. 6th ed. New York, NY: Wiley-Liss; 2002.
6. Quirke P, Williams G, Ectors N, et al. The future of the TNM staging system in colorectal cancer: time for a debate? Lancet Oncol. 2007;8:651-657. (Pubitemid 46995637)
7. Sobin LH, Gospodarowicz MK, Wittekind CH, eds. International Union Against Cancer. TNM Classification of Malignant Tumours. 7th ed. West Sussex, England: Wiley-Blackwell; 2009.
8. Nagtegaal ID, Quirke P. Colorectal tumour deposits in the mesorectum and pericolon; a critical review. Histopathology. 2007;51:141-149. (Pubitemid 47083979)
9. Ueno H, Mochizuki H, Hashiguchi Y, et al. Extramural cancer deposits without nodal structure in colorectal cancer. Optimal categorization for prognostic staging. Am J Clin Pathol. 2007;127:287-294. (Pubitemid 46797188)
10. Ueno H, Mochizuki H. Clinical significance of extrabowel skipped cancer infiltration in rectal cancer. Surg Today. 1997;27:617-622. (Pubitemid 27456043)
11. Goldstein NS, Turner JR. Pericolonic tumor deposits in patients with T3N+M0 colon adenocarcinomas. Cancer. 2000;88:2228-2238.
12. Ratto C, Ricci R, Rossi C, et al. Mesorectal microfoci adversely affect the prognosis of patients with rectal cancer. Dis Colon Rectum. 2002;45:733-743.
13. Prabhudesai A, Arif S, Finlayson CJ, et al. Impact of microscopic extranodal tumor deposits on the outcome of patientswith rectal cancer. DisColon Rectum. 2003;46:1531-1537. (Pubitemid 37429736)
14. Puppa G, Maisonneuve P, Sonzogni A, et al. Pathological assessment of pericolonic tumor deposits in advanced colonic carcinoma: relevance to prognosis and tumor staging. Mod Pathol. 2007;20:843-855. (Pubitemid 47077266)
15. Japanese Society for Cancer of the Colon and Rectum. Japanese Classification of Colorectal Carcinoma (second English edition). Tokyo, Japan: Kanehara & Co Ltd; 2009.
16. Akaike H. Information Theory and an Extension of the Maximum Likelihood Principle. Budapest, Hungary: Akademiai Kiado; 1973.
17. Harrell FE, Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361-387. (Pubitemid 26072233)
18. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2006.
19. Harrison J, Warner S, El-Zeky F, et al. The Crohn's-like lymphoid reaction in right colon cancer: results of multivariate analysis. Lab Invest. 1992;66:43A.
20. Paty PB, Enker WE, Cohen AM, et al. Treatment of rectal cancer by low anterior resection with coloanal anastomosis. Ann Surg. 1994;219:365-373. (Pubitemid 24121450)
21. Ueno H, Mochizuki H, Tamakuma S. Prognostic significance of extranodal microscopic foci discontinuous with primary lesion in rectal cancer. Dis Colon Rectum. 1998;41:55-61. (Pubitemid 28044876)
22. Ono C, Yoshinaga K, Enomoto M, et al. Discontinuous rectal cancer spread in the mesorectum and the optimal distal clearance margin in situ. Dis Colon Rectum. 2002;45:744-749. (Pubitemid 34602487)
23. Lo DS, Pollett A, Siu LL, et al. Prognostic significance of mesenteric tumor nodules in patients with stage III colorectal cancer. Cancer. 2007;112:50-54.
24. Twelves C, Wong A, Nowacki MP, et al. Capecitabine as adjuvant treatment for stage III colon cancer. New Engl J Med. 2005;352:2696-2704. (Pubitemid 41007824)
25. Andŕe T, Boni C, Navarro M, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol. 2009;27:3109-3116.